| Prevalence and Clinical Effect of IDH1 and IDH2 Mutations Among Cytogenetically Normal Acute Myeloid Leukemia Patients TAZ Salah Aref1, , , El Sayed Kamel Areida2, Mohamed Fathy Abdel Aaal2, Ola ... clinical lymphoma myeloma and leukemia 15 (9), 550-555, 2015 | 40 | 2015 |
| Prevalence and Clinical Effect of IDH1 and IDH2 Mutations Among Cytogenetically Normal Acute Myeloid Leukemia Patients TAZ Salah Aref1, , , El Sayed Kamel Areida2, Mohamed Fathy Abdel Aaal2, Ola ... clinical lymphoma myeloma and leukemia 15 (9), 550-555, 2015 | 40 | 2015 |
| Impact of serum adiponectin and leptin levels in acute leukemia S Aref, L Ibrahim, E Azmy, R Al Ashary Hematology 18 (4), 198-203, 2013 | 36 | 2013 |
| Flow cytometric MRD detection in selected mature B-cell malignancies S Böttcher, M Ritgen, M Kneba Lymphoma: Methods and Protocols, 149-174, 2013 | 33* | 2013 |
| Association of hemostatic gene polymorphisms with early-onset ischemic heart disease in Egyptian patients W Alkhiary, H Azzam, MMA Yossof, S Aref, M Othman, S El-Sharawy Clinical and Applied Thrombosis/Hemostasis 22 (6), 535-542, 2016 | 23 | 2016 |
| Fludarabine and cyclophosphamide in combination with alemtuzumab in patients with primary high-risk, relapsed or refractory chronic lymphocytic leukemia T Elter, R James, R Busch, D Winkler, M Ritgen, S Böttcher, C Kahl, ... Leukemia 26 (12), 2549-2552, 2012 | 21 | 2012 |
| Value of minimal residual disease (MRD) negative status at response evaluation in chronic lymphocytic leukemia (CLL): combined analysis of two phase III studies of the German … G Kovacs, S Boettcher, J Bahlo, S Kluth, M Ritgen, AM Fink, I Stodden, ... Blood 124 (21), 23, 2014 | 17 | 2014 |
| The prognostic relevance of BAALC and ERG expression levels in cytogenetically normal pediatric acute myeloid leukemia S Aref, T Al Khodary, TA Zeed, A El Sadiek, N El Menshawy, R Al Ashery Indian Journal of Hematology and Blood Transfusion 31, 21-28, 2015 | 16 | 2015 |
| Significance of NOTCH1 mutations détections in T-acute lymphoblastic leukemia patients TA Aref Salah Cancer biomarker 27, 157-162, 2020 | 14 | 2020 |
| Impact of serum immunoglobulins level and IL-18 promoter gene polymorphism among Egyptian patients with idiopathic thrombocytopenic purpura S Aref, MS El-Ghonemy, SA El-Aziz, T Abouzeid, M Talaab, A El-Sabbagh Hematology, 1-6, 2016 | 13 | 2016 |
| Prognostic relevance of Wilms tumor 1 (WT1) gene Exon 7 mutations in-patient with cytogenetically normal acute myeloid leukemia S Aref, S El Sharawy, M Sabry, E Azmy, DA Raouf Indian Journal of Hematology and Blood Transfusion 30, 226-230, 2014 | 10 | 2014 |
| Prognostic Value of CD200 Expression and Soluble CTLA-4 Concentrations in Intermediate and High-Risk Myelodysplastic Syndrome Patients TA Aref Salah Asian Pac J Cancer 21, 2225-2230, 2020 | 9* | 2020 |
| Prognostic Value of CD200 Expression and Soluble CTLA-4 Concentrations in Intermediate and High-Risk Myelodysplastic Syndrome Patients TA Aref Salah Asian Pac J Cancer 21, 2225-2230, 2020 | 9* | 2020 |
| Clinicopathologic effect of DNMT3A mutation in adult T-Cell Acute Lymphoblastic Leukemia S Aref, N El Menshawy, MS El-Ghonemy, T Abou Zeid, MA El-Baiomy Clinical Lymphoma Myeloma and Leukemia 16 (1), 43-48, 2016 | 9 | 2016 |
| Telomerase reverse transcriptase (TERT) A1062T mutation as a prognostic factor in Egyptian patients with acute myeloid leukemia (AML) AMES S Aref, MS El-Ghonemy, TE Abouzeid MEDICAL ONCOLOGY, 31-158, 2014 | 9 | 2014 |
| CD56 and CD19 antigens expression in acute myeloid leukemia identifies patients with adverse prognosis in Egypt S Shorbagy, R Haggag, N Alazizi, T Abouzeid Int J Science Res 5 (1), 2319-7064, 2016 | 8 | 2016 |
| Quantitative clonal dynamics define mechanisms of CLL evolution in response to combination chemotherapy DA Landau, E Tausch, S Böttcher, C Stewart, I Bozic, I Leischner, ... Blood 126 (23), 362, 2015 | 7 | 2015 |
| Impact of Bone Marrow Natural Killer Cells (NK); Soluble TNF-α and IL-32 Levels in Myelodysplastic Syndrome Patients TA Aref Salah Asian Pac J Cancer 21 (10), 2949- 2953, 2020 | 6* | 2020 |
| Prevalence and Prognostic Value of IDH1 R132 Mutation in Newly Diagnosed AML Egyptian Patients with Normal Karyotype D Salem, SA El-Aziz, N El-Menshawy, T Abouzeid, M Ebrahim Indian Journal of Hematology and Blood Transfusion, 1-7, 2015 | 6 | 2015 |
| Circulating CXCL13 could be served as a biomarker for chronic lymphocytic leukemia severity TA Aref Salah cancer biomarkers 32 (10), 2021 | 5* | 2021 |
Mohamed Sabry El-Ghonemylecture of hematology clinical pathology在 mans.edu.eg 的电子邮件经过验证
